Skip to content
2000
Volume 22, Issue 1
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Superparamagnetic iron oxide nanoparticles have gained considerable attention in drug delivery due to their superparamagnetic characteristics. SPIONs have a greater surface-to-volume ratio, size, superficial chemistry, and superparamagnetic characteristics, which allow them to be covered by external magnetic fields. These properties make SPIONs promising nanoparticles for drug delivery systems. A great advantage of the superparamagnetic characteristics is magnetic properties. SPIONs are magnetic and thoroughly demagnetized when the field of the electromagnet is pulled out. These characteristics permit their targeted delivery to a particular tissue or cell following a magnetic field. Furthermore, SPIONs can be fabricated with particular ligands, such as peptides or antibodies, to increase their efficiency in desired cells or tissues. This permits delivery, particularly to the desired cell type, increases therapeutic activity, and reduces off-target effects. Moreover, SPIONs exhibit imaging characteristics. However, this review highlights the capabilities of SPIONs for targeted drug delivery to reduce tumor cell toxicity.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cctr/10.2174/0115733947318407241023050059
2025-01-01
2026-03-11

  • From This Site

    /content/journals/cctr/10.2174/0115733947318407241023050059
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. KumarP. AgnihotriS. RoyI. Synthesis of dox drug conjugation and citric acid stabilized superparamagnetic iron-oxide nanoparticles for drug delivery.Biochem. Physiol.201615210.4172/2168‑9652.1000194
     [Google Scholar]
  2. LassenbergerA. ScheberlA. StadlbauerA. StiglbauerA. HelbichT. ReimhultE. Individually stabilized, superparamagnetic nanoparticles with controlled shell and size leading to exceptional stealth properties and high relaxivities.ACS Appl. Mater. Interfaces2017943343335310.1021/acsami.6b1293228071883
     [Google Scholar]
  3. UthamanS LeeSJ CherukulaK ChoCS ParkIK Polysaccharide-coated magnetic nanoparticles for imaging and gene therapy.Biomed. Res. Int.20175201595917510.1155/2015/959175
     [Google Scholar]
  4. MuK. ZhangS. AiT. JiangJ. YaoY. JiangL. ZhouQ. XiangH. ZhuY. YangX. ZhuW. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.Mol. Imaging20151457290.2015.0000210.2310/7290.2015.0000226044549
     [Google Scholar]
  5. VeisehO. GunnJ.W. ZhangM. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.Adv. Drug Deliv. Rev.201062328430410.1016/j.addr.2009.11.00219909778
     [Google Scholar]
  6. TartajP. MoralesM.P. González-CarreñoT. Veintemillas-VerdaguerS. SernaC.J. Advances in magnetic nanoparticles for biotechnology applications.J. Magn. Magn. Mater.2005290-291283410.1016/j.jmmm.2004.11.155
     [Google Scholar]
  7. NeubergerT. SchöpfB. HofmannH. HofmannM. von RechenbergB. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system.J. Magn. Magn. Mater.2005293148349610.1016/j.jmmm.2005.01.064
     [Google Scholar]
  8. HäfeliUO PauerGJ RobertsWK HummJL MacklisRM Magnetically directed poly(lactic acid) 90Y-microspheres: Novel agents for targeted intracavitary radiotherapy.J. Biomed. Mater. Res.19942889018
     [Google Scholar]
  9. WeinsteinJ.S. VarallyayC.G. DosaE. GahramanovS. HamiltonB. RooneyW.D. MuldoonL.L. NeuweltE.A. Superparamagnetic iron oxide nanoparticles: Diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review.J. Cereb. Blood Flow Metab.2010301153510.1038/jcbfm.2009.19219756021
     [Google Scholar]
  10. LiuF. LaurentS. FattahiH. ElstL.V. MullerR.N. Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging.Nanomedicine (Lond.)20116351952810.2217/nnm.11.1621542689
     [Google Scholar]
  11. AliN. ZhangB. ZhangH. ZamanW. LiW. ZhangQ. Key synthesis of magnetic Janus nanoparticles using a modified facile method.Particuology201417596510.1016/j.partic.2014.02.001
     [Google Scholar]
  12. PraetoriusN. MandalT. Engineered nanoparticles in cancer therapy.Recent Pat. Drug Deliv. Formul.200711375110.2174/18722110777981410419075873
     [Google Scholar]
  13. KumarC.S.S.R. MohammadF. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.Adv. Drug Deliv. Rev.201163978980810.1016/j.addr.2011.03.00821447363
     [Google Scholar]
  14. LaurentS. MahmoudiM. Superparamagnetic iron oxide nanoparticles: Promises for diagnosis and treatment of cancer.Int. J. Mol. Epidemiol. Genet.20112436739022199999
     [Google Scholar]
  15. OmoruyiI.C. OmoruyiJ.I. AghedoO.N. ArchibongU.D. IfijenI.H. Application of magnetic iron oxide nanostructures in drug delivery: A compact review.TMS 2023 152nd Annual Meeting & Exhibition Supplemental ProceedingsChamSpringer202310.1007/978‑3‑031‑22524‑6_22
     [Google Scholar]
  16. OleksaV. MackováH. PatsulaV. DydowiczováA. JanouškováO. HorákD. Doxorubicin-conjugated iron oxide nanoparticles: Surface engineering and biomedical investigation.ChemPlusChem20208561156116310.1002/cplu.20200036032496029
     [Google Scholar]
  17. VasirJ.K. LabhasetwarV. Targeted drug delivery in cancer therapy.Technol. Cancer Res. Treat.20054436337410.1177/15330346050040040516029056
     [Google Scholar]
  18. GuptaAK GuptaM Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.Biomaterials2005261839954021
     [Google Scholar]
  19. DawsonK.S. SchlegelD.J. AhnC.P. AndersonS.F. AubourgÉ. BaileyS. BarkhouserR.H. BautistaJ.E. BeifioriA. BerlindA.A. BhardwajV. BizyaevD. BlakeC.H. BlantonM.R. BlomqvistM. BoltonA.S. BordeA. BovyJ. BrandtW.N. BrewingtonH. BrinkmannJ. BrownP.J. BrownsteinJ.R. BundyK. BuscaN.G. CarithersW. CarneroA.R. CarrM.A. ChenY. ComparatJ. ConnollyN. CopeF. CroftR.A.C. CuestaA.J. da CostaL.N. DavenportJ.R.A. DelubacT. de PutterR. DhitalS. EaletA. EbelkeG.L. EisensteinD.J. EscoffierS. FanX. Filiz AkN. FinleyH. Font-RiberaA. Génova-SantosR. GunnJ.E. GuoH. HaggardD. HallP.B. HamiltonJ-C. HarrisB. HarrisD.W. HoS. HoggD.W. HolderD. HonscheidK. HuehnerhoffJ. JordanB. JordanW.P. KauffmannG. KazinE.A. KirkbyD. KlaeneM.A. KneibJ-P. Le GoffJ-M. LeeK-G. LongD.C. LoomisC.P. LundgrenB. LuptonR.H. MaiaM.A.G. MaklerM. MalanushenkoE. MalanushenkoV. MandelbaumR. ManeraM. MarastonC. MargalaD. MastersK.L. McBrideC.K. McDonaldP. McGreerI.D. McMahonR.G. MenaO. Miralda-EscudéJ. Montero-DortaA.D. MontesanoF. MunaD. MyersA.D. NaugleT. NicholR.C. NoterdaemeP. NuzaS.E. OlmsteadM.D. OravetzA. OravetzD.J. OwenR. PadmanabhanN. Palanque-DelabrouilleN. PanK. ParejkoJ.K. PârisI. PercivalW.J. Pérez-FournonI. Pérez-RàfolsI. PetitjeanP. PfaffenbergerR. PforrJ. PieriM.M. PradaF. Price-WhelanA.M. RaddickM.J. ReboloR. RichJ. RichardsG.T. RockosiC.M. RoeN.A. RossA.J. RossN.P. RossiG. Rubiño-MartinJ.A. SamushiaL. SánchezA.G. SayresC. SchmidtS.J. SchneiderD.P. ScóccolaC.G. SeoH-J. SheldenA. SheldonE. ShenY. ShuY. SlosarA. SmeeS.A. SneddenS.A. StaufferF. SteeleO. StraussM.A. StreblyanskaA. SuzukiN. SwansonM.E.C. TalT. TanakaM. ThomasD. TinkerJ.L. TojeiroR. TremontiC.A. Vargas MagañaM. VerdeL. VielM. WakeD.A. WatsonM. WeaverB.A. WeinbergD.H. WeinerB.J. WestA.A. WhiteM. Wood-VaseyW.M. YecheC. ZehaviI. ZhaoG-B. ZhengZ. The Baryon oscillation spectroscopic survey of SDSS-III.Astron. J.201314511010.1088/0004‑6256/145/1/10
     [Google Scholar]
  20. MahmoudiM. SantS. WangB. LaurentS. SenT. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy.Adv. Drug Deliv. Rev.2011631-2244610.1016/j.addr.2010.05.00620685224
     [Google Scholar]
  21. KuruBerkS. Intercourse of arbuscularmycorrhizal fungus and putrescine treatments on agro morphological and biochemical properties of strawberry festival cv.J. Plant Growth Regul.2023202312
     [Google Scholar]
  22. MaityD. MollickM.M.R. MondalD. BhowmickB. BainM.K. BankuraK. SarkarJ. AcharyaK. ChattopadhyayD. Synthesis of methylcellulose–silver nanocomposite and investigation of mechanical and antimicrobial properties.Carbohydr. Polym.20129041818182510.1016/j.carbpol.2012.07.08222944452
     [Google Scholar]
  23. TurcheniukK. TarasevychA.V. KukharV.P. BoukherroubR. SzuneritsS. Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles.Nanoscale2013522107291075210.1039/c3nr04131j24091568
     [Google Scholar]
  24. SoaresP.I.P. RomãoJ. MatosR. SilvaJ.C. BorgesJ.P. Design and engineering of magneto-responsive devices for cancer theranostics: Nano to macro perspective.Prog. Mater. Sci.202111610074210.1016/j.pmatsci.2020.100742
     [Google Scholar]
  25. HasanyS.F. AhmedI. RajanJ. RehmanA. Systematic review of the preparation techniques of iron oxide magnetic nanoparticles.Nanosci. Nanotechnol.20122614815810.5923/j.nn.20120206.01
     [Google Scholar]
  26. RostamnejadiA. SalamatiH. KameliP. AhmadvandH. Superparamagnetic behavior of La0.67Sr0.33MnO3 nanoparticles prepared via sol–gel method.J. Magn. Magn. Mater.2009321193126313110.1016/j.jmmm.2009.05.035
     [Google Scholar]
  27. LakshmananR. OkoliC. BoutonnetM. JäråsS. RajaraoG.K. Effect of magnetic iron oxide nanoparticles in surface water treatment: Trace minerals and microbes.Bioresour. Technol.201312961261510.1016/j.biortech.2012.12.13823337539
     [Google Scholar]
  28. AllenM. WillitsD. MosolfJ. YoungM. DouglasT. Protein cage constrained synthesis of ferrimagnetic iron oxide nanoparticles.Adv. Mater.200214211562156510.1002/1521‑4095(20021104)14:21<1562::AID‑ADMA1562>3.0.CO;2‑D
     [Google Scholar]
  29. HeH. ZhongY. LiangX. TanW. ZhuJ. Yan WANGC. Natural Magnetite: An efficient catalyst for the degradation of organic contaminant.Sci. Rep.2015511013910.1038/srep1013925958854
     [Google Scholar]
  30. PierceD.E. WrightP.J. Popelka-FilcoffR.S. Seeing red: An analysis of archeological hematite in east central Missouri.Archaeol. Anthropol. Sci.20201212310.1007/s12520‑019‑00984‑4
     [Google Scholar]
  31. RenG. DingH. LiY. LuA. Natural hematite as a low-cost and earth-abundant cathode material for performance improvement of microbial fuel cells.Catalysts201661015710.3390/catal6100157
     [Google Scholar]
  32. DoanL. NguyenT.T.T. TranK. HuynhK.G. Surface Modifications of Superparamagnetic Iron Oxide Nanoparticles with Chitosan, Polyethylene Glycol, Polyvinyl Alcohol, and Polyvinylpyrrolidone as Methylene Blue Adsorbent Beads.Polymers (Basel)20241613183910.3390/polym1613183939000694
     [Google Scholar]
  33. KainzQ.M. ReiserO. Polymer- and dendrimer-coated magnetic nanoparticles as versatile supports for catalysts, scavengers, and reagents.Acc. Chem. Res.201447266767710.1021/ar400236y24397296
     [Google Scholar]
  34. AshbyJ. PanS. ZhongW. Size and surface functionalization of iron oxide nanoparticles influence the composition and dynamic nature of their protein corona.ACS Appl. Mater. Interfaces2014617154121541910.1021/am503909q25144382
     [Google Scholar]
  35. WuM. ZhangD. ZengY. WuL. LiuX. LiuJ. Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly (dopamine) for magnetic field-targeting, highly sensitive MRI and photothermal cancer therapy.Nanotechnology2015261111510210.1088/0957‑4484/26/11/11510225721867
     [Google Scholar]
  36. MalekiH. SimchiA. ImaniM. CostaB.F.O. Size-controlled synthesis of superparamagnetic iron oxide nanoparticles and their surface coating by gold for biomedical applications.J. Magn. Magn. Mater.2012324233997400510.1016/j.jmmm.2012.06.045
     [Google Scholar]
  37. AkhtarN. MohammedH.A. YusufM. Al-SubaiyelA. SulaimanG.M. KhanR.A. SPIONs conjugate supported anticancer drug doxorubicin’s delivery: Current status, challenges, and prospects.Nanomaterials (Basel)20221220368610.3390/nano1220368636296877
     [Google Scholar]
  38. Dulińska-LitewkaJ. ŁazarczykA. HałubiecP. SzafrańskiO. KarnasK. KarewiczA. Superparamagnetic iron oxide nanoparticles—Current and prospective medical applications.Materials (Basel)201912461710.3390/ma1204061730791358
     [Google Scholar]
  39. KimW. SuhC.Y. ChoS.W. RohK.M. KwonH. SongK. ShonI.J. A new method for the identification and quantification of magnetite–maghemite mixture using conventional X-ray diffraction technique.Talanta20129434835210.1016/j.talanta.2012.03.00122608459
     [Google Scholar]
  40. ZyslerR.D. FioraniD. TestaA.M. Investigation of magnetic properties of interacting Fe2O3 nanoparticles.J. Magn. Magn. Mater.2001224151110.1016/S0304‑8853(00)01328‑7
     [Google Scholar]
  41. SunZ.X. SuF.W. ForslingW. SamskogP.O. Surface characteristics of magnetite in aqueous suspension.J. Colloid Interface Sci.1998197115115910.1006/jcis.1997.52399466855
     [Google Scholar]
  42. IssaB. ObaidatI. AlbissB. HaikY. Magnetic nanoparticles: Surface effects and properties related to biomedicine applications.Int. J. Mol. Sci.20131411212662130510.3390/ijms14112126624232575
     [Google Scholar]
  43. LiX. ElliottD.W. ZhangW. Zero-valent iron nanoparticles for abatement of environmental pollutants: Materials and engineering aspects.Crit. Rev. Solid State Mater. Sci.200631411112210.1080/10408430601057611
     [Google Scholar]
  44. LinM.M. KimD.K. El HajA.J. DobsonJ. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.IEEE Trans. Nanobiosci.20087429830510.1109/TNB.2008.201186419203873
     [Google Scholar]
  45. AshiqueS. GargA. MishraN. RainaN. MingL.C. TulliH.S. BehlT. RaniR. GuptaM. Nano-mediated strategy for targeting and treatment of non-small cell lung cancer (NSCLC).Naunyn Schmiedebergs Arch. Pharmacol.2023396112769279210.1007/s00210‑023‑02522‑537219615
     [Google Scholar]
  46. HildebrandtB. WustP. AhlersO. DieingA. SreenivasaG. KernerT. FelixR. RiessH. The cellular and molecular basis of hyperthermia.Crit. Rev. Oncol. Hematol.2002431335610.1016/S1040‑8428(01)00179‑212098606
     [Google Scholar]
  47. SodipoBK Abdul AzizA Sonochemical synthesis of silica-coated superparamagnetic iron oxide nanoparticles.Materials Science ForumWollerau, SwitzerlandTrans Tech Publications Ltd.2013
     [Google Scholar]
  48. MahmoudiM. LaurentS. ShokrgozarM.A. HosseinkhaniM. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: Cell “vision” versus physicochemical properties of nanoparticles.ACS Nano2011597263727610.1021/nn202108821838310
     [Google Scholar]
  49. XieM. MengF. WangP. Díaz-GarcíaA. ParkhatsM. Santos-OliveiraR. AsimM. BostanN. GuH. YangL. LiQ. YangZ. LaiH. CaiY. Surface Engineering of Magnetic Iron Oxide Nanoparticles for Breast Cancer Diagnostics and Drug Delivery.Int. J. Nanomedicine2024198437846110.2147/IJN.S47765239170101
     [Google Scholar]
  50. LiL. JiangL.L. ZengY. LiuG. Toxicity of superparamagnetic iron oxide nanoparticles: Research strategies and implications for nanomedicine.Chin. Phys. B2013221212750310.1088/1674‑1056/22/12/127503
     [Google Scholar]
  51. AshiqueS. UpadhyayA. HussainA. BagS. ChaterjeeD. RihanM. MishraN. BhattS. PuriV. SharmaA. PrasherP. SinghS.K. ChellappanD.K. GuptaG. DuaK. Green biogenic silver nanoparticles, therapeutic uses, recent advances, risk assessment, challenges, and future perspectives.J. Drug Deliv. Sci. Technol.20227710387610.1016/j.jddst.2022.103876
     [Google Scholar]
  52. MaedaH. WuJ. SawaT. MatsumuraY. HoriK. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review.J. Control. Release2000651-227128410.1016/S0168‑3659(99)00248‑510699287
     [Google Scholar]
  53. KumarM. SinghG. AroraV. MewarS. SharmaU. JagannathanN.R. SapraS. DindaA.K. KharbandaS. SinghH. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.Int. J. Nanomedicine201273503351622848174
     [Google Scholar]
  54. MeierR. HenningT.D. BoddingtonS. TavriS. AroraS. PiontekG. RudeliusM. CorotC. Daldrup-LinkH.E. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.Radiology2010255252753510.1148/radiol.1009005020413763
     [Google Scholar]
  55. KoyamaT. ShimuraM. MinemotoY. NoharaS. ShibataS. IidaY. IwashitaS. HasegawaM. KurabayashiT. HamadaH. KonoK. HondaE. AokiI. IshizakaY. Evaluation of selective tumor detection by clinical magnetic resonance imaging using antibody-conjugated superparamagnetic iron oxide.J. Control. Release2012159341341810.1016/j.jconrel.2012.01.02322300621
     [Google Scholar]
  56. IlieşB.D. YildizI. AbbasM. Peptide-conjugated nanoparticle platforms for targeted delivery, imaging, and biosensing applications.ChemBioChem20242510e20230086710.1002/cbic.20230086738551557
     [Google Scholar]
  57. HaikY. ChatterjeeJ. Jen ChenC. Synthesis and stabilization of Fe–Nd–B nanoparticles for biomedical applications.J. Nanopart. Res.20057667567910.1007/s11051‑005‑5467‑4
     [Google Scholar]
  58. KumarA. JenaP.K. BeheraS. LockeyR.F. MohapatraS. MohapatraS. Multifunctional magnetic nanoparticles for targeted delivery.Nanomedicine201061646910.1016/j.nano.2009.04.00219446653
     [Google Scholar]
  59. HeY. SongW. LeiJ. LiZ. CaoJ. HuangS. MengJ. XuH. JinZ. XueH. Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.Acta Radiol.20125391049105810.1258/ar.2012.12005523012484
     [Google Scholar]
  60. MengJ. FanJ. GalianaG. BrancaR.T. ClasenP.L. MaS. ZhouJ. LeuschnerC. KumarC.S.S.R. HormesJ. OtitiT. BeyeA.C. HarmerM.P. KielyC.J. WarrenW. HaatajaM.P. SoboyejoW.O. LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI.Mater. Sci. Eng. C20092941467147910.1016/j.msec.2008.09.039
     [Google Scholar]
  61. YuT.T. PengX.C. WangM.F. HanN. XuH.Z. LiQ.R. LiL.G. XuX. MaQ.L. LiuB. WangJ. ZhaoL. ChenX. LiT.F. Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer.J. Cancer Res. Clin. Oncol.2022148486787910.1007/s00432‑021‑03879‑x34997349
     [Google Scholar]
  62. DarweshR. ElbialyN.S. Iron oxide nanoparticles conjugated curcumin to promote high therapeutic efficacy of curcumin against hepatocellular carcinoma.Inorg. Chem. Commun.202112610848210.1016/j.inoche.2021.108482
     [Google Scholar]
  63. LiaoS.H. LiuC.H. BastakotiB.P. SuzukiN. ChangY. YamauchiY. LinF.H. WuK.C. Functionalized magnetic iron oxide/alginate core-shell nanoparticles for targeting hyperthermia.Int. J. Nanomedicine2015103315332726005343
     [Google Scholar]
  64. ReviaR.A. ZhangM. Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: Recent advances.Mater. Today201619315716810.1016/j.mattod.2015.08.02227524934
     [Google Scholar]
  65. BaeY.H. ParkK. Targeted drug delivery to tumors: Myths, reality and possibility.J. Control. Release2011153319820510.1016/j.jconrel.2011.06.00121663778
     [Google Scholar]
  66. LungwitzU. BreunigM. BlunkT. GöpferichA. Polyethylenimine-based non-viral gene delivery systems.Eur. J. Pharm. Biopharm.200560224726610.1016/j.ejpb.2004.11.01115939236
     [Google Scholar]
  67. NamgungR. SinghaK. YuM.K. JonS. KimY.S. AhnY. ParkI.K. KimW.J. Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells.Biomaterials201031144204421310.1016/j.biomaterials.2010.01.12320170956
     [Google Scholar]
  68. HwangJ.H. LeeS. KimE. KimJ.S. LeeC.H. AhnI.S. JangJ.H. Heparin-coated superparamagnetic nanoparticle-mediated adeno-associated virus delivery for enhancing cellular transduction.Int. J. Pharm.2011421239740410.1016/j.ijpharm.2011.10.01922016032
     [Google Scholar]
  69. ChengY. ZakO. AisenP. HarrisonS.C. WalzT. Structure of the human transferrin receptor-transferrin complex.Cell2004116456557610.1016/S0092‑8674(04)00130‑814980223
     [Google Scholar]
  70. KievitF.M. ZhangM. Surface engineering of iron oxide nanoparticles for targeted cancer therapy.Acc. Chem. Res.2011441085386210.1021/ar200027721528865
     [Google Scholar]
  71. LiX. WeiJ. AifantisK.E. FanY. FengQ. CuiF.Z. WatariF. Current investigations into magnetic nanoparticles for biomedical applications.J. Biomed. Mater. Res. A201610451285129610.1002/jbm.a.3565426779606
     [Google Scholar]
  72. GoodwinS. PetersonC. HohC. BittnerC. Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy.J. Magn. Magn. Mater.19991941-313213910.1016/S0304‑8853(98)00584‑8
     [Google Scholar]
  73. GoodwinS.C. BittnerC.A. PetersonC.L. WongG. Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier.Toxicol. Sci.200160117718310.1093/toxsci/60.1.17711222884
     [Google Scholar]
  74. AshiqueS. AfzalO. YasminS. HussainA. AltamimiM.A. WebsterT.J. AltamimiA.S.A. Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective.Int. J. Pharm.202363312261410.1016/j.ijpharm.2023.12261436646255
     [Google Scholar]
  75. TietzeR. ZalogaJ. UnterwegerH. LyerS. FriedrichR.P. JankoC. PöttlerM. DürrS. AlexiouC. Magnetic nanoparticle-based drug delivery for cancer therapy.Biochem. Biophys. Res. Commun.2015468346347010.1016/j.bbrc.2015.08.02226271592
     [Google Scholar]
  76. AshiqueS. AfzalO. HussainA. ZeyaullahM. AltamimiM.A. MishraN. AhmadM.F. DuaK. AltamimiA.S.A. AnandK. It’s all about plant derived natural phytoconstituents and phytonanomedicine to control skin cancer.J. Drug Deliv. Sci. Technol.20238410449510.1016/j.jddst.2023.104495
     [Google Scholar]
  77. SamrotA.V. SahithyaC.S. Selvarani AJ. PurayilS.K. PonnaiahP. A review on synthesis, characterization and potential biological applications of superparamagnetic iron oxide nanoparticles.Curr. Res. Green Sustain. Chem.2021410004210.1016/j.crgsc.2020.100042
     [Google Scholar]
  78. KimD.K. ChangJ.H. KangY.J. Efficient internalization of peptide-conjugated SPIONs in dendritic cells for tumor targeting.J. Nanosci. Nanotechnol.20121275191519810.1166/jnn.2012.637922966544
     [Google Scholar]
  79. KoteraY. ShimizuK. MuléJ.J. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization.Cancer Res.200161228105810911719436
     [Google Scholar]
  80. JungS.H. LeeY.K. LeeH.J. ChoiN.R. VoM.C. HoangM.D. LimM.S. Nguyen-PhamT.N. KimH.J. LeeJ.J. Dendritic cells loaded with myeloma cells pretreated with a combination of JSI-124 and bortezomib generate potent myeloma-specific cytotoxic T lymphocytes in vitro.Exp. Hematol.201442427428110.1016/j.exphem.2013.12.00824407159
     [Google Scholar]
  81. GrifantiniR. TarantaM. GherardiniL. NaldiI. ParriM. GrandiA. GiannettiA. TombelliS. LucariniG. RicottiL. CampagnoliS. De CamilliE. PelosiG. BaldiniF. MenciassiA. VialeG. PileriP. CintiC. Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer.J. Control. Release2018280768610.1016/j.jconrel.2018.04.05229733876
     [Google Scholar]
  82. JiangS. EltoukhyA.A. LoveK.T. LangerR. AndersonD.G. Lipidoid-coated iron oxide nanoparticles for efficient DNA and siRNA delivery.Nano Lett.20131331059106410.1021/nl304287a23394319
     [Google Scholar]
  83. LamA.K. FrabuttD. LiL. XiaoW. Chemical modifications of the capsid for redirecting and improving the efficacy of adeno-associated virus vectors.Hum. Gene Ther.20213223-241433143810.1089/hum.2021.12434254844
     [Google Scholar]
  84. SteitzB. HofmannH. KamauS.W. HassaP.O. HottigerM.O. von RechenbergB. Hofmann-AmtenbrinkM. Petri-FinkA. Characterization of PEI-coated superparamagnetic iron oxide nanoparticles for transfection: Size distribution, colloidal properties and DNA interaction.J. Magn. Magn. Mater.2007311130030510.1016/j.jmmm.2006.10.1194
     [Google Scholar]
  85. HildebrandtN. HermsdorfD. SignorellR. SchmitzS.A. DiederichsenU. Superparamagnetic iron oxide nanoparticles functionalized with peptides by electrostatic interactions.ARKIVOC200620075799010.3998/ark.5550190.0008.508
     [Google Scholar]
  86. KoM.J. MinS. HongH. YooW. JooJ. ZhangY.S. KangH. KimD.H. Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging.Bioact. Mater.202432669710.1016/j.bioactmat.2023.09.01537822917
     [Google Scholar]
  87. HeZ. ZhongC. SuS. XuM. WuH. CaoY. Enhanced power-conversion efficiency in polymer solar cells using an inverted device structure.Nat. Photonics20126959159510.1038/nphoton.2012.190
     [Google Scholar]
  88. HuangC. LiC. ShiG. Graphene based catalysts.Energy Environ. Sci.20125108848886810.1039/c2ee22238h
     [Google Scholar]
  89. UnsoyG. YalcinS. KhodadustR. MutluP. OnguruO. GunduzU. Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy.Biomed. Pharmacother.201468564164810.1016/j.biopha.2014.04.00324880680
     [Google Scholar]
  90. Petri-FinkA. ChastellainM. Juillerat-JeanneretL. FerrariA. HofmannH. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.Biomaterials200526152685269410.1016/j.biomaterials.2004.07.02315585272
     [Google Scholar]
  91. SkourasA. MourtasS. MarkoutsaE. De GoltsteinM.C. WallonC. CatoenS. AntimisiarisS.G. Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties.Nanomedicine20117557257910.1016/j.nano.2011.06.01021704597
     [Google Scholar]
  92. SundaresanV. MenonJ.U. RahimiM. NguyenK.T. WadajkarA.S. Dual-responsive polymer-coated iron oxide nanoparticles for drug delivery and imaging applications.Int. J. Pharm.20144661-21710.1016/j.ijpharm.2014.03.01624607216
     [Google Scholar]
  93. RezaeiB. YariP. SandersS.M. WangH. ChughV.K. LiangS. MostufaS. XuK. WangJ.P. Gómez-PastoraJ. WuK. Magnetic nanoparticles: A review on synthesis, characterization, functionalization, and biomedical applications.Small2024205230484810.1002/smll.20230484837732364
     [Google Scholar]
  94. LamannaG. Kueny-StotzM. Mamlouk-ChaouachiH. GhobrilC. BaslyB. BertinA. MiladiI. BilloteyC. PourroyG. Begin-ColinS. Felder-FleschD. Dendronized iron oxide nanoparticles for multimodal imaging.Biomaterials201132338562857310.1016/j.biomaterials.2011.07.02621864894
     [Google Scholar]
  95. JainT.K. MoralesM.A. SahooS.K. Leslie-PeleckyD.L. LabhasetwarV. Iron oxide nanoparticles for sustained delivery of anticancer agents.Mol. Pharm.20052319420510.1021/mp050001415934780
     [Google Scholar]
  96. WeissR.B. DonehowerR.C. WiernikP.H. OhnumaT. GrallaR.J. TrumpD.L. BakerJ.R.Jr Van EchoD.A. Von HoffD.D. Leyland-JonesB. Hypersensitivity reactions from taxol.J. Clin. Oncol.1990871263126810.1200/JCO.1990.8.7.12631972736
     [Google Scholar]
  97. GelderblomH. VerweijJ. van ZomerenD.M. BuijsD. OuwensL. NooterK. StoterG. SparreboomA. Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.Clin. Cancer Res.2002841237124111948138
     [Google Scholar]
  98. KuchmaE. ZolotukhinP. BelanovaA. SoldatovM. LastovinaT. KubrinS. NikolskyA. MirmikovaL. SoldatovA. Low toxic maghemite nanoparticles for theranostic applications.Int. J. Nanomedicine2017126365637110.2147/IJN.S14036828919740
     [Google Scholar]
  99. AlexiouC. ArnoldW. KleinR.J. ParakF.G. HulinP. BergemannC. ErhardtW. WagenpfeilS. LübbeA.S. Locoregional cancer treatment with magnetic drug targeting.Cancer Res.200060236641664811118047
     [Google Scholar]
  100. AshleyC.E. CarnesE.C. PhillipsG.K. PadillaD. DurfeeP.N. BrownP.A. HannaT.N. LiuJ. PhillipsB. CarterM.B. CarrollN.J. JiangX. DunphyD.R. WillmanC.L. PetsevD.N. EvansD.G. ParikhA.N. ChackerianB. WhartonW. PeabodyD.S. BrinkerC.J. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers.Nat. Mater.201110538939710.1038/nmat299221499315
     [Google Scholar]
  101. LiuX. SituA. KangY. VillabrozaK.R. LiaoY. ChangC.H. DonahueT. NelA.E. MengH. Irinotecan delivery by lipid-coated mesoporous silica nanoparticles shows improved efficacy and safety over liposomes for pancreatic cancer.ACS Nano20161022702271510.1021/acsnano.5b0778126835979
     [Google Scholar]
  102. JustinC. SamrotA.V. Preparation, characterization and utilization of core-shell superparamagnetic iron oxide nanoparticles for curcumin delivery.PLoS One2018137e020044010.1371/journal.pone.020044030021002
     [Google Scholar]
  103. WuL.C. ZhangY. SteinbergG. QuH. HuangS. ChengM. BlissT. DuF. RaoJ. SongG. PisaniL. DoyleT. ConollyS. KrishnanK. GrantG. WintermarkM. A review of magnetic particle imaging and perspectives on neuroimaging.AJNR Am. J. Neuroradiol.201940220621210.3174/ajnr.A589630655254
     [Google Scholar]
  104. FuA. WilsonR.J. SmithB.R. MullenixJ. EarhartC. AkinD. GuccioneS. WangS.X. GambhirS.S. Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects.ACS Nano2012686862686910.1021/nn301670a22857784
     [Google Scholar]
  105. KalberT. OrdidgeK. SouthernP. LoebingerM. KyrtatosP. PankhurstQ. LythgoeM. JanesS. Hyperthermia treatment of tumors by mesenchymal stem cell-delivered superparamagnetic iron oxide nanoparticles.Int. J. Nanomedicine2016111973198310.2147/IJN.S9425527274229
     [Google Scholar]
  106. YaparE.A. ÖzdemirM.N. DurgunM.E. DağıstanÖ.A. CavaluS. ÖzsoyY. KartalM. Nanodelivery approaches of phytoactives for skin cancers: Current and future perspectives.Curr. Pharm. Biotechnol.202438616742
     [Google Scholar]
  107. LaurentS. SaeiA.A. BehzadiS. PanahifarA. MahmoudiM. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: Opportunities and challenges.Expert Opin. Drug Deliv.20141191449147010.1517/17425247.2014.92450124870351
     [Google Scholar]
  108. AshiqueS. SandhuN.K. ChawlaV. ChawlaP.A. Targeted drug delivery: Trends and perspectives.Curr. Drug Deliv.202118101435145510.2174/156720181866621060916130134151759
     [Google Scholar]
  109. BaoF. YaoJ.L. GuR.A. Synthesis of magnetic Fe2O3/Au core/shell nanoparticles for bioseparation and immunoassay based on surface-enhanced Raman spectroscopy.Langmuir20092518107821078710.1021/la901337r19552373
     [Google Scholar]
  110. KeransF.F.A. LungaroL. AzferA. SalterD.M. The potential of intrinsically magnetic mesenchymal stem cells for tissue engineering.Int. J. Mol. Sci.20181910315910.3390/ijms1910315930322202
     [Google Scholar]
  111. LiC. ArmstrongJ.P.K. PenceI.J. Kit-AnanW. PuetzerJ.L. Correia CarreiraS. MooreA.C. StevensM.M. Glycosylated superparamagnetic nanoparticle gradients for osteochondral tissue engineering.Biomaterials2018176243310.1016/j.biomaterials.2018.05.02929852377
     [Google Scholar]
  112. AshiqueS. UpadhyayA. GulatiM. SinghD. ChawlaP.A. ChawlaV. One-dimensional polymeric nanocomposites in drug delivery systems.Curr. Nanosci.202319682583910.2174/1573413719666230110110706
     [Google Scholar]
  113. JaishankarM. TsetenT. AnbalaganN. MathewB.B. BeeregowdaK.N. Toxicity, mechanism and health effects of some heavy metals.Interdiscip. Toxicol.201472607210.2478/intox‑2014‑000926109881
     [Google Scholar]
  114. AttallahO.A. Al-GhobashyM.A. NebsenM. SalemM.Y. Removal of cationic and anionic dyes from aqueous solution with magnetite/pectin and magnetite/silica/pectin hybrid nanocomposites: Kinetic, isotherm and mechanism analysis.RSC Advances2016614114611148010.1039/C5RA23452B
     [Google Scholar]
  115. YuvakkumarR. ElangoV. RajendranV. KannanN. Preparation and characterization of zero valent iron nanoparticles.Dig. J. Nanomater. Biostruct.20116417711776
     [Google Scholar]
  116. Peffi FerreiraL.F. Mazzi de OliveiraT. TomaS.H. ToyamaM.M. ArakiK. AvanziL.H. Superparamagnetic iron oxide nanoparticles (SPIONs) conjugated with lipase Candida antarctica A for biodiesel synthesis.RSC Advances20201063384903849610.1039/D0RA06215D35517526
     [Google Scholar]
  117. VeeramaniS. RavindranE. MayakrishnanV. IlangovanR. Silica coated Iron Oxide Nanoparticles - Performance Evaluation for Drug Delivery Applications.Silicon20241652129213810.1007/s12633‑023‑02822‑8
     [Google Scholar]
  118. AshiqueS. KumarS. HussainA. MishraN. GargA. GowdaB.H.J. FaridA. GuptaG. DuaK. Taghizadeh-HesaryF. A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer.J. Health Popul. Nutr.20234217410.1186/s41043‑023‑00423‑037501216
     [Google Scholar]
  119. LiF. OuyangJ. ChenZ. ZhouZ. Milon EssolaJ. AliB. WuX. ZhuM. GuoW. LiangX.J. Nanomedicine for T-Cell Mediated Immunotherapy.Adv. Mater.20243622230177010.1002/adma.20230177036964936
     [Google Scholar]
  120. AshiqueS. MishraN. MantryS. GargA. KumarN. GuptaM. KarS.K. IslamA. MohantoS. SubramaniyanV. Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders.Naunyn Schmiedebergs Arch. Pharmacol.2024202413210.1007/s00210‑024‑03392‑139196392
     [Google Scholar]
  121. WangB. WuW. LuH. WangZ. XinH. Enhanced anti-tumor of pep-1 modified superparamagnetic iron oxide/PTX loaded polymer nanoparticles.Front. Pharmacol.20199155610.3389/fphar.2018.0155630723412
     [Google Scholar]
  122. Luque-MichelE. LemaireL. Blanco-PrietoM.J. SPION and doxorubicin-loaded polymeric nanocarriers for glioblastoma theranostics.Drug Deliv. Transl. Res.202111251552310.1007/s13346‑020‑00880‑833405212
     [Google Scholar]
  123. Second Affiliated Hospital, School of Medicine, Zhejiang UniversityA phase I clinical trial of neoadjuvant chemotherapy with/​without SPIONs/​SMF for patients with osteosarcoma.2020Available From: https://www.clinicaltrials.gov/study/NCT04316091?cond=cancer,%20SPIONS&rank=1
  124. Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Radiotherapy with iron oxide nanoparticles (SPION) on MR-linac for primary & metastatic hepatic cancers.2024Available From: https://www.clinicaltrials.gov/study/NCT04682847?cond=cancer,%20SPIONS&rank=4
  125. SadhukhaT. WiedmannT.S. PanyamJ. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy.Biomaterials201334215163517110.1016/j.biomaterials.2013.03.06123591395
     [Google Scholar]
  126. AbdelazizH.M. GaberM. Abd-ElwakilM.M. MabroukM.T. ElgoharyM.M. KamelN.M. KabaryD.M. FreagM.S. SamahaM.W. MortadaS.M. ElkhodairyK.A. FangJ.Y. ElzoghbyA.O. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates.J. Control. Release201826937439210.1016/j.jconrel.2017.11.03629180168
     [Google Scholar]
  127. PriceD.N. StrombergL.R. KundaN.K. MuttilP. In vivo pulmonary delivery and magnetic-targeting of dry powder nano-in-microparticles.Mol. Pharm.201714124741475010.1021/acs.molpharmaceut.7b0053229068693
     [Google Scholar]
  128. KikumoriT. KobayashiT. SawakiM. ImaiT. Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes.Breast Cancer Res. Treat.2009113343544110.1007/s10549‑008‑9948‑x18311580
     [Google Scholar]
  129. MarchalF. PicE. PonsT. DubertretB. BolotineL. GuilleminF. [Quantum dots in oncological surgery: The future for surgical margin status].Bull. Cancer200895121149115319091647
     [Google Scholar]
  130. JavidA. AhmadianS. SabouryA.A. KalantarS.M. Rezaei-ZarchiS. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: Synthesis and anticancer effect against human ovarian cancer cells.Chem. Biol. Drug Des.201382329630610.1111/cbdd.1214523594157
     [Google Scholar]
  131. AbdolahiM. Shahbazi-GahroueiD. LaurentS. SermeusC. FirozianF. AllenB.J. BoutryS. MullerR.N. Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb‐conjugated SPIONs for specific detection of prostate cancer.Contrast Media Mol. Imaging20138217518410.1002/cmmi.151423281290
     [Google Scholar]
  132. NageshP.K.B. JohnsonN.R. BoyaV.K.N. ChowdhuryP. OthmanS.F. Khalilzad-SharghiV. HafeezB.B. GanjuA. KhanS. BehrmanS.W. ZafarN. ChauhanS.C. JaggiM. YallapuM.M. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.Colloids Surf. B Biointerfaces201614482010.1016/j.colsurfb.2016.03.07127058278
     [Google Scholar]
  133. Nayerpour DizajT. Jafari-GharabaghlouD. Farhoudi Sefidan JadidM. JahanbanR. RahimiM. FarajollahiM. MohsenzadeganM. ZarghamiN. Fabrication of antibody conjugated super magnetic oxide nanoparticles for early detection of prostate cancer.Asian Pac. J. Cancer Prev.20232462089209710.31557/APJCP.2023.24.6.208937378940
     [Google Scholar]
  134. WahajuddinN. AroraS. Superparamagnetic iron oxide nanoparticles: Magnetic nanoplatforms as drug carriers.Int. J. Nanomedicine201273445347110.2147/IJN.S3032022848170
     [Google Scholar]
  135. KandasamyG. MaityD. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.Int. J. Pharm.2015496219121810.1016/j.ijpharm.2015.10.05826520409
     [Google Scholar]
  136. UnterwegerH. SubatzusD. TietzeR. JankoC. PoettlerM. StiegelschmittA. SchusterM. MaakeC. BoccacciniA. AlexiouC. Hypericin-bearing magnetic iron oxide nanoparticles for selective drug delivery in photodynamic therapy.Int. J. Nanomedicine2015106985699610.2147/IJN.S9233626648714
     [Google Scholar]
  137. AminML P-glycoprotein inhibition for optimal drug delivery.Drug Target Insights201372734
     [Google Scholar]
  138. RicciM. MiolaM. MultariC. BorroniE. CanutoR.A. CongiustaN. VernèE. FollenziA. MuzioG. PPARs are mediators of anti-cancer properties of superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with conjugated linoleic acid.Chem. Biol. Interact.201829291410.1016/j.cbi.2018.07.00329986832
     [Google Scholar]
  139. TongL. ZhaoM. ZhuS. ChenJ. Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.Front. Med.20115437938710.1007/s11684‑011‑0162‑622198749
     [Google Scholar]
  140. WaddingtonD.E.J. BoeleT. MaschmeyerR. KuncicZ. RosenM.S. High-sensitivity in vivo contrast for ultra-low field magnetic resonance imaging using superparamagnetic iron oxide nanoparticles.Sci. Adv.2020629eabb099810.1126/sciadv.abb099832733998
     [Google Scholar]
  141. GleichB. WeizeneckerJ. Tomographic imaging using the nonlinear response of magnetic particles.Nature200543570461214121710.1038/nature0380815988521
     [Google Scholar]
  142. BuzugT.M. BringoutG. ErbeM. GräfeK. GraeserM. GrüttnerM. HalkolaA. SattelT.F. TennerW. WojtczykH. HaegeleJ. VogtF.M. BarkhausenJ. Lüdtke-BuzugK. Magnetic particle imaging: Introduction to imaging and hardware realization.Z. Med. Phys.201222432333410.1016/j.zemedi.2012.07.00422909418
     [Google Scholar]
  143. LindemannA. FraederichB.M. PriesR. WollenbergB. Lüdtke-BuzugK. GraefeK. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells.Int. J. Nanomedicine201495025504010.2147/IJN.S6387325378928
     [Google Scholar]
  144. MaedaH. NakamuraH. FangJ. The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo.Adv. Drug Deliv. Rev.2013651717910.1016/j.addr.2012.10.00223088862
     [Google Scholar]
  145. AshiqueS. UpadhyayA. KumarN. ChauhanS. MishraN. Metabolic syndromes responsible for cervical cancer and advancement of nanocarriers for efficient targeted drug delivery- A review.Adv. Cancer Biol. Metastasis2022410004110.1016/j.adcanc.2022.100041
     [Google Scholar]
  146. KimD. LeeE.S. OhK.T. GaoZ.G. BaeY.H. Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.Small20084112043205010.1002/smll.20070127518949788
     [Google Scholar]
  147. AshiqueS. AlmohaywiB. HaiderN. YasminS. HussainA. MishraN. GargA. siRNA-based nanocarriers for targeted drug delivery to control breast cancer.Adv. Cancer Biol. Metastasis2022410004710.1016/j.adcanc.2022.100047
     [Google Scholar]
  148. Fei ChinC. Yuan Qiang WongD. JothibasuR. Han AngW. Anticancer platinum (IV) prodrugs with novel modes of activity.Curr. Top. Med. Chem.201111212602261210.2174/15680261179804077822039869
     [Google Scholar]
  149. WankhedeM. BourasA. KaluzovaM. HadjipanayisC.G. Magnetic nanoparticles: An emerging technology for malignant brain tumor imaging and therapy.Expert Rev. Clin. Pharmacol.20125217318610.1586/ecp.12.122390560
     [Google Scholar]
  150. HadjipanayisC.G. MachaidzeR. KaluzovaM. WangL. SchuetteA.J. ChenH. WuX. MaoH. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.Cancer Res.201070156303631210.1158/0008‑5472.CAN‑10‑102220647323
     [Google Scholar]
  151. Maier-HauffK. UlrichF. NestlerD. NiehoffH. WustP. ThiesenB. OrawaH. BudachV. JordanA. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.J. Neurooncol.2011103231732410.1007/s11060‑010‑0389‑020845061
     [Google Scholar]
  152. NikolaevB.P. MarchenkoY.Y. YakovlevaL.Y. ZiminaT.M. SolovievA.V. LuchininV.V. PetrovA.V. ScharafutdinovaT.A. DobrodumovA.V. Magnetic epidermal growth factor conjugate for targeted delivery to the grafted tumor in a mouse model.IEEE Trans. Magn.201349142943510.1109/TMAG.2012.2223203
     [Google Scholar]
  153. KullbergE.B. NestorM. GeddaL. Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: Uptake and processing.Pharm. Res.200320222923610.1023/A:102222320446012636161
     [Google Scholar]
  154. MamotC. DrummondD.C. GreiserU. HongK. KirpotinD.B. MarksJ.D. ParkJ.W. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.Cancer Res.200363123154316112810643
     [Google Scholar]
  155. McFarlandJ HussarB De BreyC SnyderT WangX Wilkinson-FlickerS GebrekristosS ZhangJ RathbunA BarmerA Bullock MannF. The condition of education 2017. NCES 2017-144 - ERIC.2017
  156. LiX. FengJ. MengY. HanQ. WuF. LiJ. A unified MRC framework for named entity recognition.arXiv:1910114762019
     [Google Scholar]
  157. RaoY. ChenW. LiangX. HuangY. MiaoJ. LiuL. LouY. ZhangX. WangB. TangR. ChenZ. LuX. Epirubicin-loaded superparamagnetic iron-oxide nanoparticles for transdermal delivery: Cancer therapy by circumventing the skin barrier.Small201511223924710.1002/smll.20140077524925046
     [Google Scholar]
  158. SamrotA.V. CS. Sruthi PD. SelvaraniA.J. PR. PP. PonnaiahP. RT. PattammadathS. PurayilS.K. Mohamed JavadP.T. PI. Production and utilization of spions for in-vitro drug release and x-ray imaging.J. Pure Appl. Microbiol.20201421317132210.22207/JPAM.14.2.27
     [Google Scholar]
  159. KhaniabadiP.M. Shahbazi-GahroueiD. MajidA.M.S.A. KhaniabadiB.M. Study the Anti-MUC1 antibody-based iron oxide nanoparticles on three-dimension spheroid and breast cancer (MCF-7) cell imaging.Polish Journal of Medical Physics and Engineering2019252697710.2478/pjmpe‑2019‑0010
     [Google Scholar]
  160. LiuF. LeW. MeiT. WangT. ChenL. LeiY. CuiS. ChenB. CuiZ. ShaoC. In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody.Int. J. Nanomedicine2016112195220727274243
     [Google Scholar]
  161. LeeC.M. JeongH.J. KimE.M. KimD.W. LimS.T. KimH.T. ParkI.K. JeongY.Y. KimJ.W. SohnM.H. Superparamagnetic iron oxide nanoparticles as a dual imaging probe for targeting hepatocytes in vivo.Magn. Reson. Med.20096261440144610.1002/mrm.2212319859969
     [Google Scholar]
  162. ShiJ. YuX. WangL. LiuY. GaoJ. ZhangJ. MaR. LiuR. ZhangZ. PEGylated fullerene/iron oxide nanocomposites for photodynamic therapy, targeted drug delivery and MR imaging.Biomaterials201334379666967710.1016/j.biomaterials.2013.08.04924034498
     [Google Scholar]
  163. MosaferJ. AbnousK. TafaghodiM. MokhtarzadehA. RamezaniM. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.Eur. J. Pharm. Biopharm.2017113607410.1016/j.ejpb.2016.12.00928012991
     [Google Scholar]
  164. TsaveO. PsarrouM. KastrinakiG. PapachristouE. PapiR. ZaspalisV. NalbandianL. SarafidisC. Choli-PapadopoulouT. VamvakakiM. ChatzidoukasC. Functional polysaccharide-coated SPIONs for in vitro mRNA delivery in breast cancer cells.Mater. Adv.20245135410543210.1039/D4MA00010B
     [Google Scholar]
  165. PantA. SinghG. BarnwalR.P. SharmaT. SinghB. QbD-driven development and characterization of superparamagnetic iron oxide nanoparticles (SPIONS) of a bone-targeting peptide for early detection of osteoporosis.Int. J. Pharm.202465412393610.1016/j.ijpharm.2024.12393638417727
     [Google Scholar]
  166. TanL.K.S. HowC.W. LowL.E. OngB.H. LohJ.S. LimS.Y. OngY.S. FooJ.B. Magnetic-guided targeted delivery of zerumbone/SPION co-loaded in nanostructured lipid carrier into breast cancer cells.J. Drug Deliv. Sci. Technol.20238710483010.1016/j.jddst.2023.104830
     [Google Scholar]
  167. WangZ. WangY. LiH. LanY. ZengZ. YaoJ. LiM. XiaH. Fabrication of Etoposide-loaded superparamagnetic iron oxide nanoparticles (SPIONs) induced apoptosis in glioma cancer cells.Process Biochem.202312812613610.1016/j.procbio.2023.02.026
     [Google Scholar]
  168. MekseriwattanaW. GuardiaP. HerreroB.T. de la FuenteJ.M. KuhakarnC. RoigA. KatewongsaK.P. Riboflavin–citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells.Nanoscale Adv.2022481988199810.1039/D2NA00015F36133415
     [Google Scholar]
  169. AdibfarS. MasjediA. NazerA. RashidiB. KarpishehV. IzadiS. HassanniaH. Gholizadeh NavashenaqJ. MohammadiH. Hojjat-FarsangiM. TarokhianH. Jadidi-NiaraghF. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.Life Sci.202230912100810.1016/j.lfs.2022.12100836179812
     [Google Scholar]
  170. MahmoudiM. HofmannH. Rothen-RutishauserB. Petri-FinkA. Assessing the in vitro and in vivotoxicity of superparamagnetic iron oxide nanoparticles.Chem. Rev.201211242323233810.1021/cr200259622216932
     [Google Scholar]
  171. WidderK.J. MorrisR.M. PooreG.A. HowardD.P. SenyeiA.E. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: Total remission in Yoshida sarcoma-bearing rats.Eur. J. Cancer Clin. Oncol.198319113513910.1016/0277‑5379(83)90408‑X6682771
     [Google Scholar]
  172. BelanovaA.A. GavalasN. MakarenkoY.M. BelousovaM.M. SoldatovA.V. ZolotukhinP.V. Physicochemical properties of magnetic nanoparticles: Implications for biomedical applications in vitro and in vivo.Oncol. Res. Treat.201841313914310.1159/00048502029485418
     [Google Scholar]
  173. Vakili-GhartavolR. Momtazi-BorojeniA.A. Vakili-GhartavolZ. AiyelabeganH.T. JaafariM.R. RezayatS.M. Arbabi BidgoliS. Toxicity assessment of superparamagnetic iron oxide nanoparticles in different tissues.Artif. Cells Nanomed. Biotechnol.202048144345110.1080/21691401.2019.170985532024389
     [Google Scholar]
  174. LaurentS. DutzS. HäfeliU.O. MahmoudiM. Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles.Adv. Colloid Interface Sci.20111661-282310.1016/j.cis.2011.04.00321601820
     [Google Scholar]
  175. LewinskiN ColvinV DrezekR. Cytotoxicity of nanoparticles.Small2008412649
     [Google Scholar]
  176. AnkamwarB. LaiT.C. HuangJ.H. LiuR.S. HsiaoM. ChenC.H. HwuY.K. Biocompatibility of Fe 3 O 4 nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells.Nanotechnology201021707510210.1088/0957‑4484/21/7/07510220090199
     [Google Scholar]
  177. ShenC.C. LiangH.J. WangC.C. LiaoM.H. JanT.R. Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity.Int. J. Nanomedicine201272729273722701318
     [Google Scholar]
  178. LuC. JiJ. ZhuX. TangP. ZhangQ. ZhangN. WangZ. WangX.J. ChenW. HuJ. DuY.Z. YuR.S. T2-weighted magnetic resonance imaging of hepatic tumor guided by SPIO-loaded nanostructured lipid carriers and ferritin reporter genes.ACS Appl. Mater. Interfaces2017941355483556110.1021/acsami.7b0987928944659
     [Google Scholar]
  179. NarayanaS. GowdaB.H.J. HaniU. ShimuS.S. PaulK. DasA. AshiqueS. AhmedM.G. TarighatM.A. AbdiG. Inorganic nanoparticle-based treatment approaches for colorectal cancer: Recent advancements and challenges.J. Nanobiotechnology202422142710.1186/s12951‑024‑02701‑339030546
     [Google Scholar]
/content/journals/cctr/10.2174/0115733947318407241023050059
Loading
SPIONs: Paving the Way for Targeted Drug Delivery to Cancer Cells
Curr Cancer Ther Rev 22, 1 (2026); https://doi.org/10.2174/0115733947318407241023050059
/content/journals/cctr/10.2174/0115733947318407241023050059
/content/journals/cctr/10.2174/0115733947318407241023050059
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): chemotherapy; clinical trials; drug delivery systems; future aspects; hyperthermia; Superparamagnetic iron oxide nanoparticles; targeted delivery; toxicity

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test